Trilogy Enhanced Income Fund

Invest in a portfolio of cash, fixed interest investments and other financial assets with returns enhanced via investment in the Trilogy Monthly Income Trust.

  • Net distribution rate. 6.10%PA1
  • Competitive income returns
  • Portfolio diversification
  • Proactive risk management
  • Minimum investment. $5,000

1December 2024 net distribution rate annualised.
Past performance is not a reliable indicator of future performance. Variable rate.

Introducing the
Trilogy Enhanced Income Fund

The Trilogy Enhanced Income Fund invests directly and indirectly in a portfolio of cash, fixed interest investments and other financial assets such as a range of short to medium term bank deposits, bills of exchange, promissory notes, bonds, fixed or floating rate debt securities and income securities.

To enhance returns, part of the portfolio is invested in the Trilogy Monthly Income Trust (Trust). The Trust is a pooled mortgage trust that invests in loans secured by registered first mortgages of Australian property.

Platform Availability

  • Allan Gray
  • Australian Money Market
  • Hub24
  • Macquarie Wrap
  • Mason Stevens
  • Netwealth
  • OneVue
  • PowerWrap
  • Praemium
  • Dash / uXchange

Fund Rating

*Click the image to download the report.

We are pleased to announce that the Trilogy Enhanced Income Fund has retained a ‘VERY STRONG’ rating from independent research agency, Foresight Analytics, in their November 2023 report2.

“The Fund is managed by an experienced, knowledgeable, and professional team that is well-versed in managing registered Managed Investment Schemes/Managed Funds.”  –SQM Research3

2The information contained in the Foresight Analytics report and encapsulated in the investment rating is of a general nature only. The report and rating reflect the opinion of Foresight Analytics and Ratings Pty Limited (AFSL 494552). It does not take into account an individual’s objectives, financial situation, or needs. Professional advice should be sought before making an investment decision. A fee has been paid by the fund manager for the production of the report and investment rating.

3The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Fund information

The Trilogy Enhanced Income Fund has delivered consistent returns in a low yield environment to its investors since launch in 20174.

  • Open for investment
  • Minimum investment $5,000
  • Access to funds in 30 days, while the Fund is liquid (see PDS)
  • Unit price of $1.005

  • Option to reinvest

4Past performance is not a reliable indicator of future performance.
5Whilst the unit price is fixed, capital losses can occur in circumstances where an asset of the Fund incurs a capital loss.

Historical performance

Data provided in the below table is current as at 31 December 2024.

Net Rate Annualised 6.05%PA
3 months (%PA)
Historical Average Net Rate Annualised
6.05%PA
1 years (%PA)
Historical Average Net Rate Annualised
6.16%PA
5 year (%PA)
Historical Average Net Rate Annualised
4.00%PA
Since launch in 2017 (%PA)
Historical Average Net Rate Annualised
-- %PA
Historical Performance 6,7
1 month 3 month 6 month 1 year 3 year 5 year Inception
Return 0.52% 1.54% 3.10% 6.20% 4.92% 4.19% 4.16%
Target Return 0.50% 1.47% 2.95% 5.85% 4.68% 3.49% 3.27%
Excess Return 0.02% 0.07% 0.15% 0.35% 0.24% 0.70% 0.89%

6 All distribution rates quoted are variable, net of fees, costs and taxes and assume no distribution reinvestment. Past performance is not a reliable indicator of future performance.

7 3-year, 5-year and inception data are reported on a per annum basis. The target benchmark is the Official Cash Rate target plus 1.50% p.a assuming reinvestment of distribution but before fees and expenses and taxes, over a rolling 12 months period.

How it works

In this short video, we step you through how the Trust works and what you can expect from your investment.

Click on the play icon to start the video.

Investment overview

Distributions

The Fund aims to pay a competitive monthly return.

Liquidity

Requests for withdrawals are accepted each day. A 30-day notice period is required for withdrawals, but requests may be processed and paid sooner at the discretion of Trilogy. You must note that up to six months is allowed under the Constitution.

Easy to manage

Once your initial investment has been made, our experienced fund managers take care of administration and asset management for you. You will receive regular updates on the performance of your investment and our Investor Relations team is available to answer any of your queries.

Risks

You should be aware that investing in the Trilogy Enhanced Income Fund involves risks that could lead to the loss of part or all of your capital or diminished returns. For example, there are investment and structural risks associated with the underlying investments and separate risks associated with the underlying asset classes of cash and cash-style investments and indirect investment in a portfolio of loans secured by registered first mortgages over Australian real estate. You should read the PDS in full.

Trust updates

Date Document Type
11.10.2024 Annual Report 2024 Investor update
10.04.2024 New Product Disclosure Statement (PDS)- April 2024 Investor update
10.04.2024 New Target Market Determination (TMD)- April 2024 Investor update
30.06.2023 Annual Report 2023 Investor update
30.09.2022 Target Market Determination (TMD) – September 2022 Investor update
30.06.2022 Annual Report 2022 Investor update
01.10.2021 Target Market Determination (TMD) – October 2021 Investor update
30.06.2021 Annual Report 2021 Investor update
28.07.2020 Product Disclosure Statement (PDS) – July 2020 Investor update
30.06.2020 Annual Report 2020 Investor update

Still have questions?

Check out our frequently asked questions for investors.
If you can’t find the answer you’re looking for, get in touch with our Investor Relations team, who will be able to point you in the right direction.